Snapshot from Jul 19, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Regulatory / GRAIL class action lawsuit
Regulatory class action

GRAIL class action lawsuit

Analysis based on 6 articles · First reported Jun 10, 2026 · Last updated Jul 10, 2026

Sentiment
-40
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

Illumina — Holy Grail's stock price collapsed by over 50% following the trial failure announcement, erasing billions in market value. The class action lawsuit may lead to additional financial liabilities and reputational damage for the company.

Healthcare Biotechnology
Event Summary

Berger Montague PC filed a class action lawsuit against Illumina — Holy Grail, Inc. on behalf of investors who purchased Illumina — Holy Grail common stock between May 13, 2025 and February 19, 2026. The suit alleges that Illumina — Holy Grail and its executives made misleading statements about the NHS-Galleri trial, failing to disclose that the trial's three-year follow-up was insufficient to demonstrate a statistically significant reduction in late-stage cancers. On February 19, 2026, Illumina — Holy Grail announced the trial failed to meet its primary endpoint, causing its stock to drop 50.55% in one day. The deadline for lead plaintiff is August 4, 2026.

Key Actions
100 Illumina — Holy Grail announced trial endpoint not observed
80 Berger Montague filed class action lawsuit Illumina — Holy Grail
Entities Involved
subs
Illumina — Holy Grail
Illumina — Holy Grail is the defendant in the class action lawsuit; its stock plummeted 50.55% after the trial failure disclosure, and it faces potential legal and financial consequences.
Importance 100.0 Sentiment -80.0
priv
Berger Montague
Berger Montague is the law firm representing the plaintiff class; the lawsuit enhances its profile in securities litigation.
Importance 60.0 Sentiment 20.0
exch
Nasdaq
Nasdaq is the exchange where Illumina — Holy Grail is listed; the event has no direct impact on the exchange.
Importance 10.0 Sentiment 0.0
per
Andrew Abramowitz
Andrew Abramowitz is a contact attorney at Berger Montague for the lawsuit; his role is administrative.
Importance 5.0 Sentiment 0.0
per
Caitlin Adorni
Caitlin Adorni is a contact attorney at Berger Montague for the lawsuit; her role is administrative.
Importance 5.0 Sentiment 0.0
Relationships
Berger Montague related ↔ Andrew Abramowitz
Berger Montague related ↔ Caitlin Adorni
Andrew Abramowitz co-counsel ↔ Caitlin Adorni Andrew Abramowitz directly collaborates with Caitlin Adorni as co-counsel, jointly managing investor inquiries for numer
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.